Epigenetic Drugs and Their Immune Modulating Potential in Cancers

Epigenetic drugs are used for the clinical treatment of hematologic malignancies; however, their therapeutic potential in solid tumors is still under investigation. Current evidence suggests that epigenetic drugs may lead to antitumor immunity by increasing antigen presentation and may enhance the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yingying, Turcan, Sevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868629/
https://www.ncbi.nlm.nih.gov/pubmed/35203421
http://dx.doi.org/10.3390/biomedicines10020211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868629/
https://www.ncbi.nlm.nih.gov/pubmed/35203421
http://dx.doi.org/10.3390/biomedicines10020211

Ejemplares similares